As the most common serious neurological condition in the U.S., epilepsy affects roughly 3.4 million Americans. It's what drives biopharmaceutical researchers to fight back with innovative medicines like targeted treatments that could transform the lives of patients living with the disease.
Lung cancer counts for 25% of all cancer deaths in the U.S. That's why every day, researchers search relentlessly to unearth more innovative breakthroughs. Thanks to their dedication, there are now 240 immuno-oncology treatments in development to give hope and a future for patients with cancer.
Thanks to advances in modern medicine, there has been significant progress for breast cancer patients in the last decade. Groundbreaking innovations in personalized medicine are changing the course of treatment to create potential first-in-class therapies and the promise of a cancer-free future.